Abstract
Objectives
To investigate the seroprevalence of hepatitis B surface antigen (HBsAg) in pregnant women and possible risk factors for perinatal hepatitis B virus (HBV) transmission.
Methods
Four thousand pregnant women were evaluated using history, examination, and test for serum HBsAg using commercial enzyme immunoassay kits. For HBsAg positive women, liver function tests and a test for hepatitis B e antigen (HBeAg) was done. HBV DNA analysis was done by polymerase chain reaction (PCR).
Results
Of 4,000 women studied, 37 (0.9%) tested positive for HBsAg. Of these 37 women, 6 (16%) presented with acute hepatitis and 31 (84%) were asymptomatic. The highest HBsAg positivity rate was seen in the age group of 21–25 years (1.15%) followed by 26–30 years (0.86%). Assessment of risk factors revealed history of tattooing in 29/37 (78.4%) women. HBeAg was positive in 21 of 37 (56.8%) women. Of the 16 HBeAg negative women, 5 were positive for HBV DNA and anti-HBe antibody, 6 had only anti-HBe antibody and 5 had neither HBV DNA nor anti-HBe. Vertical transmission was seen in 65% (13/20) of babies born to mothers who were positive for HBeAg and HBV DNA. In contrast, it was only 9.1% (1/11) for babies born to mothers who were negative for both HBeAg and HBV DNA. Of the 25 babies delivered vaginally, 15 (60%) developed vertical transmission. None of the four babies delivered by elective cesarean section had evidence of vertical transmission.
Conclusions
Seroprevalence of HBsAg in antenatal women was found to be 0.9%. HBe-antigen and HBV DNA positivity was associated with a higher chance of vertical transmission
Similar content being viewed by others
References
Sevens CE, Neurath RA, Beasly RP, Szmuness W. HBeAg and anti-HBe detection by radioimmunoassay. Correlation with vertical transmission of hepatitis B virus in Taiwan. J Med Virol. 1979;3:237–41.
Xu ZY, Liu CB, Francis DP, et al. Prevention of perinatal acquisition of hepatitis B virus carriage using vaccine: preliminary report of a random double-blind placebo-controlled and comparative trail. Pediatrics. 1985;76:713–8.
Zhang SL, Yue YF, Bai GQ, Shi L, Jiang H. Mechanism of intrauterine infection of hepatitis B virus. World J Gastroenterol. 2004;10:437–8.
Beasley RP, Hwang LY. Postnatal infectivity of hepatitis B surface antigen-carrier mothers. J Infect Dis. 1983;147:185–90.
Yang X, Cui MX, Liu BG. Breast-feeding by mothers with positive serum hepatitis B virus test. Zhonghua Fu Chan Ke Za Zhi. 1994;29:586–8. 635.
Wright TL. Introduction to chronic hepatitis B infection. Am J Gastroenterol. 2006;101 Suppl 1:S1–6.
Elinav E, Ben-Dov IZ, Shapira Y, et al. Acute hepatitis A infection in pregnancy is associated with high rates of gestational complications and preterm labor. Gastroenterology. 2006;130:1129–34.
Ornoy A, Tenenbaum A. Pregnancy outcome following infections by coxsackie, echo, measles, mumps, hepatitis, polio and encephalitis viruses. Reprod Toxicol. 2006;21:446–57.
Tse KY, Ho LF, Lao T. The impact of maternal HBsAg carrier status on pregnancy outcomes: a case-control study. J Hepatol. 2005;43:771–5.
Dafallah SE, EL-Agib FH, Bushra GO. Maternal mortality in a teaching hospital in Sudan. Saudi Med J. 2003;24:369–72.
Laurent C, Henzel D, Mulanga-Kabeya C, Maertens G, Larouze B, Delaporte E. Seroepidemiological survey of hepatitis C virus among commercial sex workers and pregnant women in Kinshasa, Democratic Republic of Congo. Int J Epidemiol. 2001;30:872–7.
Nacro B, Dao B, Dahourou H, et al. HBs antigen carrier state in pregnant women in Bobo Dioulasso (Burkina Faso). Dakar Méd. 2000;45:188–90.
Simpore J, Ilboudo D, Samandoulougou A, Guardo P, Castronovo P, Musumeci S. HCV and HIV co-infection in pregnant women attending St. Camille Medical Centre in Ouagadougou (Burkina Faso). J Med Virol. 2005;75:209–12.
Simpore J, Savadogo A, Ilboudo D, et al. Toxoplasma gondii, HCV, and HBV seroprevalence and co-infection among HIV-positive and -negative pregnant women in Burkina Faso. J Med Virol. 2006;78:730–3.
Wurie IM, Wurie AT, Gevao SM. Sero-prevalence of hepatitis B virus among middle to high socio-economic antenatal population in Sierra Leone. West Afr J Med. 2005;24:18–20.
Tandon BN, Acharya SK, Tandon A. Epidemiology of hepatitis B virus in India. Gut. 1996;38 suppl:556–9.
Lindh M, Gonzalez JE, Norkrans G, Horal P. Genotyping of hepatitis B virus by restriction pattern analysis of a pre-S amplicon. J Virol Methods. 1998;72:163–74.
Mishra D, Singh HP. Kuppuswamy’s socio-economic status scale: a revision. Indian J Pediatr. 2003;70:614–8.
Papaevangelou G, Farmaki G, Kada H. Hepatitis B maternal-fetal transmission in Southern Europe. Intervirology. 1998;41:197–200.
Alrowaily MA, Abolfotouh MA, Ferwanah MS. Hepatitis B virus sero-prevalence among pregnant females in Saudi Arabia. Saudi J Gastroenterol. 2008;14:70–2.
Bertolini DA, Pinho JRR, Saraceni CP, Moreira RC, Granato CFH, Carrilho FJ. Prevalence of serological markers of hepatitis B virus in pregnant women from Paraná State, Brazil. Braz J Med Biol Res. 2006;39:1083–90.
Biswas SC, Gupta I, Ganguly NK, et al. Prevalence of hepatitis B surface antigen in pregnant mothers and its perinatal transmission. Trans R Soc Trop Med Hyg. 1989;83:698–700.
Shenoy S, Baliga S, Parasnath HV. Prevalence of hepatitis B surface antigen (HBsAg) in pregnant women in south Kanara district, Karnataka State, India. Trop Doct. 2004;34:98–9.
Batayneh N, Bdour S. Risk of perinatal transmission of hepatitis B virus in Jordan. Infect Dis Obstet Gynecol. 2002;10:127–32.
Makuwa M, Caron M, Souquière S, Malonga-Mouelet G, Mahé A, Kazanji M. Prevalence and genetic diversity of hepatitis B and delta viruses in pregnant women in Gabon: molecular evidence that hepatitis delta virus clade 8 originates from and is endemic in central Africa. J Clin Microbiol. 2008;46:754–6.
Okoth F, Mbuthia J, Gatheru Z, et al. Seroprevalence of hepatitis B markers in pregnant women in Kenya. East Afr Med J. 2006;83:485–93.
Khalil MK, Al-Mazrou YY, Al-Jeffri M, et al. Serosurvey of hepatitis B surface antigen in pregnant Saudi women. East Mediterr Health J. 2005;11:640–7.
Al Awaidy S, Abu-Elyazeed R, Al Hosani H, et al. Sero-epidemiology of hepatitis B infection in pregnant women in Oman, Qatar and the United Arab Emirates. J Infect. 2006;52:202–6.
Nayak NC, Panda SK, Zuckerman AJ, et al. Dynamics and impact of perinatal transmission of hepatitis B virus in North India. J Med Virol. 1987;21:137–45.
Panda SK, Ramesh R, Rao KV, et al. Comparative evaluation of the immunogenicity of yeast-derived (recombinant) and plasma-derived hepatitis B vaccine in infants. J Med Virol. 1991;35:297–302.
Gill HH, Majumdar PD, Dhunjibhoy KR, et al. Prevalence of hepatitis B e antigen in pregnant women and patients with liver disease. J Assoc Physicians India. 1995;43:247–8.
Mittal SK, Rao S, Rastogi A, et al. Hepatitis B: potential of perinatal transmission in India. Trop Gastroenterol. 1996;17:190–2.
Madzime S, Adem M, Mahomed K, Woelk GB, Mudzamiri S, Williams MA. Hepatitis B virus infection among pregnant women delivering at Harare Maternity Hospital, Harare Zimbabwe, 1996 to 1997. Cent Afr J Med. 1999;45:195–8.
Reinus J, Leinlin E. Viral hepatitis in pregnancy. Clin Liver Dis. 1999;3:115–30.
Sharma R, Malik A, Rattan A, Iraqi A, Maheshwari V, Dhawan R. Hepatitis B virus infection in pregnant women and its transmission to infants. J Trop Pediatr. 1996;42:352–4.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dwivedi, M., Misra, S.P., Misra, V. et al. Seroprevalence of hepatitis B infection during pregnancy and risk of perinatal transmission. Indian J Gastroenterol 30, 66–71 (2011). https://doi.org/10.1007/s12664-011-0083-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12664-011-0083-y